Page last updated: 2024-11-01

niceritrol and Hyperlipoproteinemias

niceritrol has been researched along with Hyperlipoproteinemias in 4 studies

Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.

Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.

Research Excerpts

ExcerptRelevanceReference
"Prophylactic treatment of the hyperlipoproteinemia with the drugs niceritrol (Perycit) and beta-pyridylcarbinol (Ronicol) significantly reduced the elevated plasma cholesterol level and reduced the degree of atherosclerosis in the abdominal aorta and the coronary arteries."1.27[Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs]. ( Jacobsson, L, 1986)
"Niceritrol treatment was associated with increased blood glucose, decreased K value, elevated fasting serum insulin and serum insulin at 60 min during IVGTT."1.26Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol. ( Hellsing, K; Lithell, H; Vessby, B, 1982)
"Niceritrol treatment significantly reduced the Chol/TG ratio in VLDL while no such effect was seen during clofibrate administration."1.26Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease. ( Borberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1979)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lithell, H2
Vessby, B2
Hellsing, K1
Murase, T1
Gustafsson, IB1
Borberg, J1
Jacobsson, L1

Reviews

1 review available for niceritrol and Hyperlipoproteinemias

ArticleYear
[High Lp (a) concentrations].
    Ryoikibetsu shokogun shirizu, 1998, Issue:19 Pt 2

    Topics: Arteriosclerosis; Blood Component Removal; Coronary Artery Disease; Humans; Hyperlipoproteinemias; H

1998

Other Studies

3 other studies available for niceritrol and Hyperlipoproteinemias

ArticleYear
Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol.
    Atherosclerosis, 1982, Volume: 43, Issue:2-3

    Topics: Aged; Arteriosclerosis; Blood Glucose; Body Weight; Clofibrate; Dietary Carbohydrates; Female; Gluco

1982
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Atherosclerosis, 1979, Volume: 33, Issue:4

    Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipopr

1979
[Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1986, Jul-15, Volume: 41, Issue:14

    Topics: Animals; Arteries; Arteriosclerosis; Cholesterol; Hypercholesterolemia; Hyperlipoproteinemias; Hypol

1986